heart palpitations - Nursing Case Study

Pathophysiology

• Primary mechanism: Sympathetic Nervous System Activation - Stress, anxiety, or physical exertion can lead to increased catecholamine release, stimulating beta-adrenergic receptors, which accelerates heart rate and force of contraction, causing palpitations.

• Secondary mechanism: Ectopic Pacemaker Activity - Abnormal electrical impulses originating outside the sinoatrial node can lead to premature contractions or arrhythmias, giving rise to the sensation of palpitations.

• Key complication: Insufficient Cardiac Output - Persistent palpitations may lead to compromised cardiac performance, causing inadequate blood supply to vital organs, potentially resulting in dizziness or syncope.

Patient Profile

Demographics:

45-year-old female, school teacher

History:

• Key past medical history: Hypertension, anxiety disorder

• Current medications: Lisinopril, Sertraline

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Heart palpitations

• Key symptoms: Irregular heartbeat, shortness of breath, occasional dizziness, mild chest discomfort

• Vital signs: Blood pressure 145/90 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decides to conduct further diagnostic tests to pinpoint the cause of the patient's heart palpitations and assess any potential complications. An electrocardiogram (ECG) is performed, revealing occasional premature atrial contractions (PACs) and a sinus tachycardia at a rate of 110 bpm. Due to the patient's persistent symptoms and history of hypertension, a 24-hour Holter monitor is ordered to provide a more comprehensive analysis of her cardiac rhythm over an extended period. Blood tests, including electrolytes, thyroid function tests, and cardiac biomarkers, are also ordered to identify any underlying metabolic or hormonal imbalances.

The lab results indicate slightly elevated thyroid-stimulating hormone (TSH) levels, suggesting subclinical hypothyroidism, which could contribute to her symptoms. Electrolyte levels, including potassium and magnesium, are within normal limits, ruling out electrolyte imbalances as a cause of her palpitations. Cardiac biomarkers are negative, reducing immediate concern for acute coronary syndrome. However, the Holter monitor records several episodes of supraventricular tachycardia (SVT), particularly during periods of increased stress or exertion. This finding correlates with the patient's history of anxiety and suggests a potential link between her emotional state and cardiac symptoms.

Based on these diagnostic results, the clinical team considers adjusting her current treatment regimen. The possibility of beta-blocker therapy is discussed to help manage her heart rate and mitigate the effects of sympathetic nervous system activation. Additionally, addressing her thyroid function with appropriate endocrinological consultation may be necessary. The team also emphasizes the need for lifestyle modifications, including stress management techniques, to reduce anxiety-induced palpitations. These steps aim to stabilize her cardiac status and prevent further complications, setting the stage for the next phase of her care plan.

Section 2

Change in Patient Status:

After implementing the initial intervention strategy, including the commencement of a low-dose beta-blocker and the introduction of stress management practices, the patient's condition shows initial signs of improvement. Her heart rate stabilizes, with fewer episodes of supraventricular tachycardia noted on follow-up Holter monitoring. However, during a routine clinic visit, the patient reports new-onset fatigue, mild dizziness, and a sensation of being unusually cold, despite the recent warm weather. These symptoms prompt a reassessment of her clinical status to ensure that her treatment plan remains appropriate and effective.

Further evaluation reveals a blood pressure reading of 98/60 mmHg, indicating mild hypotension, likely secondary to the beta-blocker therapy. Her heart rate is now consistently at 82 bpm, suggesting a well-controlled tachycardia but possibly contributing to her symptoms of dizziness and fatigue. Repeat thyroid function tests show an increase in TSH to 6.5 mIU/L, confirming a progression to overt hypothyroidism, possibly exacerbated by the beta-blocker, which can mask symptoms and complicate the clinical picture. These findings necessitate a review of her medication regimen and consideration for initiating levothyroxine therapy to address her thyroid dysfunction.

The clinical team, acknowledging the intricate interplay between her cardiovascular and endocrine health, decides to adjust her treatment plan. The beta-blocker dosage is reduced to address hypotension while maintaining heart rate control. Concurrently, an endocrinologist is consulted to initiate thyroid hormone replacement therapy. The team emphasizes the importance of follow-up appointments to monitor her response to these adjustments, aiming to alleviate her symptoms while preventing further complications. This step in her care plan highlights the need for careful monitoring and dynamic treatment adjustments in managing her complex health issues.

Section 3

Following the adjustment in her treatment plan, the patient returns for a follow-up appointment two weeks later. During this visit, she reports a noticeable improvement in her energy levels and a reduction in dizziness, suggesting a positive response to the reduced beta-blocker dosage and the initiation of levothyroxine therapy. However, she also mentions experiencing intermittent swelling in her ankles and mild shortness of breath during exertion, raising concerns about potential fluid retention or cardiac function changes.

A physical examination reveals mild bilateral pitting edema in the lower extremities and clear lung fields on auscultation, with no obvious signs of pulmonary congestion. Her vital signs show a blood pressure of 105/65 mmHg and a heart rate of 78 bpm. These observations, while relatively stable, prompt the clinical team to order a series of diagnostic tests to explore the underlying cause of her new symptoms. An echocardiogram is performed, showing mild left ventricular hypertrophy but normal ejection fraction, ruling out significant heart failure.

Additionally, repeat laboratory tests reveal normal serum electrolytes but a slight elevation in serum creatinine at 1.3 mg/dL, indicating a potential mild decline in renal function. The clinical team concludes that while her hypothyroidism and tachycardia are improving, the emergence of edema and renal function changes necessitates ongoing surveillance. They decide to closely monitor her renal function, adjust her fluid intake recommendations, and consider further cardiology input if symptoms persist. This proactive approach underscores the importance of continuous evaluation and adaptation of the treatment strategy to manage her evolving clinical picture effectively.

Section 4

Two weeks following her last appointment, the patient returns to the clinic with new complaints that warrant further investigation. She reports that the swelling in her ankles has become more pronounced, extending to her calves by the end of the day, and her shortness of breath now occurs even with minimal exertion, such as walking across a room. She denies any chest pain or palpitations, but describes a persistent feeling of fatigue, which is notably different from the energy improvement she initially experienced after her medication adjustment. These symptoms prompt immediate concern for the clinical team, who suspect worsening fluid retention or another underlying issue affecting her cardiac or renal function.

Upon examination, the patient's vital signs reveal a blood pressure of 110/70 mmHg and a heart rate of 82 bpm, remaining stable. However, she exhibits more significant bilateral lower extremity pitting edema, now at a 2+ level. Her lung auscultation remains clear, with no crackles or wheezes, ruling out acute pulmonary congestion. Given the progression of her symptoms, the team orders additional diagnostic tests, including repeat serum creatinine and B-type natriuretic peptide (BNP) levels, a chest X-ray, and a 24-hour urine collection to assess renal function more thoroughly.

The new laboratory results reveal that her serum creatinine has risen to 1.5 mg/dL, suggesting further decline in renal function. The BNP level is slightly elevated at 150 pg/mL, which is not markedly high but indicates some degree of cardiac strain. The chest X-ray shows no signs of pulmonary edema but does reveal a mild cardiomegaly, consistent with her previous echocardiographic findings of left ventricular hypertrophy. These results lead the clinical team to consider the possibility of early-stage heart failure with preserved ejection fraction, compounded by potential renal insufficiency. The team emphasizes the need for a careful balance between managing her fluid status and avoiding further renal compromise, considering consultation with a nephrologist and cardiologist to refine her management plan. This approach highlights the interconnectedness of cardiac and renal function and the necessity of integrated care to address her evolving clinical challenges.

Section 5

As the multidisciplinary team delves deeper into the patient's case, they decide to adjust her diuretic therapy to better manage her fluid overload while being cautious of her renal function. They initiate a low-dose loop diuretic with close monitoring of electrolytes and renal parameters, aiming to alleviate her edema without exacerbating her renal insufficiency. Over the following week, the patient is instructed to monitor her weight daily, maintain a low-sodium diet, and report any sudden weight changes or worsening symptoms.

During a follow-up visit, the patient notes some improvement in her leg swelling, though she still experiences significant fatigue and exertional dyspnea. Her weight has stabilized, with only minor fluctuations, and she denies any new symptoms such as dizziness or orthostatic hypotension. Vital signs reveal a blood pressure of 108/68 mmHg and a heart rate of 80 bpm, showing no significant change. However, repeat laboratory tests indicate that her serum creatinine has slightly increased to 1.7 mg/dL, suggesting that her renal function remains a concern. Electrolytes are within normal ranges, with potassium at 4.2 mEq/L and sodium at 138 mEq/L.

The team contemplates the possibility of cardiorenal syndrome, where the dysfunction of one organ system adversely affects the other. They consider adjusting her diuretic regimen further or exploring alternative therapies such as the addition of a mineralocorticoid receptor antagonist to improve both cardiac and renal outcomes. The patient is scheduled for a comprehensive evaluation by a nephrologist to explore potential underlying causes of her renal impairment and discuss the feasibility of renal-protective strategies. This collaborative approach underscores the complexity of her condition and the importance of balancing interventions to optimize both cardiac and renal health without tipping the scales toward further complications.